Thursday, September 4, 2008

Teva Introduces Nicardipine Hydrochloride Injection

September 3, 2008 – Teva Health Systems is pleased to announce the introduction and availability of the first generic Nicardipine Hydrochloride Injection. This product is AP rated to Cardene®* I.V. Nicardipine HCl Injection is available as 2.5 mg/mL-25 mg, in single dose amber glass vials.

The details can be read here.

No comments: